Hale David F

EDGAR CIK 0001024004

Oncternal Therapeutics, Inc. - ONCT

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director
Direct Buys
1
$6,455
714 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$2,405
266 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
02/23/2024
02/27/2024
Buy
714 @ $9.04
 $6,455 714 (100.00%) Direct
02/23/2024
02/27/2024
Buy
266 @ $9.04
 $2,405 29,673 (0.90%) Indirect - By Hale BioPharma Ventures, LLC